Myers C. Daniel 4
4 · Kala Pharmaceuticals, Inc. · Filed Oct 19, 2021
Insider Transaction Report
Form 4
Myers C. Daniel
Director
Transactions
- Award
Stock Option (right to buy)
2021-10-15+42,000→ 42,000 totalExercise: $2.21Exp: 2031-10-14→ Common Stock (42,000 underlying)
Footnotes (1)
- [F1]This option was granted on October 15, 2021 and vests with respect to 1/3rd of the shares underlying the option on October 15, 2022 and as to an additional 1/36th of the shares underlying the option at the end of each successive one-month period thereafter until October 15, 2024.